TCIM
LFCR icon

TIAA CREF Investment Management’s Lifecore Biomedical LFCR Stock Holding History

TIAA CREF Investment Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$689K Sell
56,067
-724
-1% -$8.84K ﹤0.01% 2483
2018
Q4 		$672K Hold
56,791
– – ﹤0.01% 2454
2018
Q3 		$818K Sell
56,791
-1,941
-3% -$26.8K ﹤0.01% 2521
2018
Q2 		$875K Sell
58,732
-6,887
-10% -$95.7K ﹤0.01% 2545
2018
Q1 		$856K Buy
65,619
+776
+1% +$10.2K ﹤0.01% 2513
2017
Q4 		$817K Sell
64,843
-10,408
-14% -$132K ﹤0.01% 2561
2017
Q3 		$975K Hold
75,251
– – ﹤0.01% 2528
2017
Q2 		$1.12M Buy
75,251
+745
+1% +$10.4K ﹤0.01% 2488
2017
Q1 		$894K Sell
74,506
-5,690
-7% -$72K ﹤0.01% 2563
2016
Q4 		$1.11M Sell
80,196
-4,175
-5% -$57.8K ﹤0.01% 2472
2016
Q3 		$1.13K Sell
84,371
-340
-0.4% -$4.12K ﹤0.01% 2482
2016
Q2 		$911K Buy
84,711
+292
+0.3% +$3.22K ﹤0.01% 2561
2016
Q1 		$886K Sell
84,419
-3,326
-4% -$36.5K ﹤0.01% 2538
2015
Q4 		$1.04M Hold
87,745
– – ﹤0.01% 2556
2015
Q3 		$1.02M Sell
87,745
-2,769
-3% -$36.7K ﹤0.01% 2561
2015
Q2 		$1.31M Sell
90,514
-17,794
-16% -$257K ﹤0.01% 2557
2015
Q1 		$1.51M Sell
108,308
-2,920
-3% -$40.3K ﹤0.01% 2396
2014
Q4 		$1.54M Sell
111,228
-5,868
-5% -$75.8K ﹤0.01% 2411
2014
Q3 		$1.43M Sell
117,096
-3,390
-3% -$42.3K ﹤0.01% 2432
2014
Q2 		$1.5M Buy
120,486
+18,076
+18% +$213K ﹤0.01% 2472
2014
Q1 		$1.14M Hold
102,410
– – ﹤0.01% 2567
2013
Q4 		$1.24M Sell
102,410
-3,370
-3% -$40.2K ﹤0.01% 2543
2013
Q3 		$1.29M Sell
105,780
-529
-0.5% -$7.38K ﹤0.01% 2466
2013
Q2 		$1.4M Buy
+106,309
New +$1.47M ﹤0.01% 2368

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

TIAA CREF Investment Management's LFCR Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Lifecore Biomedical (LFCR) stake by 1.3% in Q1 2019, selling an estimated $8.84K and leaving 56,067 shares worth $689K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

TIAA CREF Investment Management first reported a position in LFCR in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.54M in Q4 2014. 91 funds tracked by Wall St. Rank hold LFCR as of Q1 2019.

  • TIAA CREF Investment Management held 56,067 shares of Lifecore Biomedical worth $689K as of Q1 2019.
  • TIAA CREF Investment Management sold 724 Lifecore Biomedical shares in Q1 2019, an estimated $8.84K.
  • Lifecore Biomedical made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2483 holding.
  • TIAA CREF Investment Management first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Lifecore Biomedical position peaked at $1.54M in Q4 2014.
  • 91 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.